Restylane, Juvederm, and other derma fillers are being linked to severe side effects, including allergies and anaphylactic shock. Next Tuesday, the Food & Drug Administration (FDA) will discuss questions and concerns for the labeling of these derma fillers.

Derma fillers were approved 20 years ago, but the most marketed kinds were approved 10 years ago. For the past six years, FDA has received 930 reports of adverse side effects. These include allergies, anaphylactic shock, mild swelling, infections and disfigurements. However, the FDA has not disclosed which derma filler treatments were involved with these side effects.

With the upcoming meet, the FDA wants to confirm the connection to the side effects and act upon possible improvements for the treatment. If the studies are verified, there will be drastic changes to how derma fillers are studied and labeled.